{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T03:46:14Z","timestamp":1792035974511,"version":"4.4.0"},"reference-count":78,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T00:00:00Z","timestamp":1791763200000},"content-version":"vor","delay-in-days":284,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment and Research Communications"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.ctarc.2026.101486","type":"journal-article","created":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:03:32Z","timestamp":1792022612000},"page":"101486","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Microbiota modulation in colorectal cancer: A scoping review of its potential role in toxicity mitigation and treatment response"],"prefix":"10.1016","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0176-7310","authenticated-orcid":false,"given":"Daniel","family":"Rizky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2159-4576","authenticated-orcid":false,"given":"Adriyan","family":"Pramono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8654-6746","authenticated-orcid":false,"given":"Budi","family":"Setiawan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5003-1292","authenticated-orcid":false,"given":"Eko Adhi","family":"Pangarsa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6093-5049","authenticated-orcid":false,"given":"Damai","family":"Santosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9755-893X","authenticated-orcid":false,"given":"Catharina","family":"Suharti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctarc.2026.101486_bib0001","article-title":"Molecular basis, diagnostic approaches, and therapeutic strategies in colorectal cancer\u2014comprehensive review","volume":"26","author":"Kowalska","year":"2025","journal-title":"Int. J. Mol. Sci. Internet"},{"key":"10.1016\/j.ctarc.2026.101486_bib0002","doi-asserted-by":"crossref","first-page":"495","DOI":"10.4240\/wjgs.v15.i4.495","article-title":"Current and emerging therapeutic approaches for colorectal cancer: a comprehensive review","volume":"15","author":"Kumar","year":"2023","journal-title":"World J. Gastrointest. Surg. Internet"},{"key":"10.1016\/j.ctarc.2026.101486_bib0003","article-title":"Advances in targeted and chemotherapeutic strategies for colorectal cancer: current insights and future directions","volume":"13","author":"Shaham","year":"2025","journal-title":"Biomed. Internet"},{"key":"10.1016\/j.ctarc.2026.101486_bib0004","article-title":"Current perspective and treatment strategies in targeted therapy for colorectal cancer","volume":"10","author":"Maurya","year":"2024","journal-title":"Clin Cancer Drugs Internet"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101486_bib0005","doi-asserted-by":"crossref","first-page":"5","DOI":"10.34172\/mejdd.2022.251","article-title":"Gastrointestinal and pancratohepatobiliary cancers: a comprehensive review on epidemiology and risk factors worldwide","volume":"14","author":"Hormati","year":"2022","journal-title":"Middle East. J. Dig. Dis."},{"key":"10.1016\/j.ctarc.2026.101486_bib0006","article-title":"Current approaches, challenges, and future perspectives in colorectal cancer therapeutics and integrated care","author":"Jafarlou","year":"2025","journal-title":"Asian Pac. J. Cancer Care Internet"},{"key":"10.1016\/j.ctarc.2026.101486_bib0007","article-title":"Stage IV colorectal cancer management and treatment","volume":"12","author":"Dominguez","year":"2023","journal-title":"J. Clin. Med. Internet"},{"issue":"23","key":"10.1016\/j.ctarc.2026.101486_bib0008","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1056\/NEJMoa2017699","article-title":"Pembrolizumab in microsatellite-instability-high advanced colorectal cancer","volume":"383","author":"Andr\u00e9","year":"2020","journal-title":"N. Engl. J. Med. Internet"},{"issue":"17","key":"10.1016\/j.ctarc.2026.101486_bib0009","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1056\/NEJMoa1908075","article-title":"Encorafenib, Binimetinib, and Cetuximab in BRAF V600E-mutated colorectal cancer","volume":"381","author":"Kopetz","year":"2019","journal-title":"N. Engl. J. Med. Internet"},{"issue":"23","key":"10.1016\/j.ctarc.2026.101486_bib0010","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1056\/NEJMoa2308795","article-title":"Sotorasib plus Panitumumab in refractory colorectal cancer with mutated KRAS G12C","volume":"389","author":"Fakih","year":"2023","journal-title":"N. Engl. J. Med. Internet"},{"issue":"18","key":"10.1016\/j.ctarc.2026.101486_bib0011","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1056\/NEJMoa2214963","article-title":"Trifluridine-Tipiracil and Bevacizumab in refractory metastatic colorectal cancer","volume":"388","author":"Prager","year":"2023","journal-title":"N. Engl. J. Med. Internet"},{"issue":"10395","key":"10.1016\/j.ctarc.2026.101486_bib0012","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0140-6736(23)00772-9","article-title":"Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer (FRESCO-2): an international, multicentre, randomised, double-blind, phase 3 study","volume":"402","author":"Dasari","year":"2023","journal-title":"Lancet Lond. Engl. Internet"},{"issue":"4","key":"10.1016\/j.ctarc.2026.101486_bib0013","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1080\/1750743X.2025.2483656","article-title":"Nutritional conditions and PFS and OS in cancer immunotherapy: the MOUSEION-010 meta-analysis","volume":"17","author":"Vitale","year":"2025","journal-title":"Immunotherapy"},{"issue":"5","key":"10.1016\/j.ctarc.2026.101486_bib0014","doi-asserted-by":"crossref","first-page":"352","DOI":"10.3390\/biology13050352","article-title":"Associations between \u201ccancer risk\u201d, \u201cinflammation\u201d and \u201cmetabolic syndrome\u201d: a scoping review","volume":"13","author":"Vitale","year":"2024","journal-title":"Biology"},{"key":"10.1016\/j.ctarc.2026.101486_bib0015","article-title":"Dietary factors modulating colorectal carcinogenesis","volume":"13","author":"Vernia","year":"2021","journal-title":"Nutr. Internet"},{"key":"10.1016\/j.ctarc.2026.101486_bib0016","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1093\/jnci\/djaf098","article-title":"Post-diagnosis dietary and lifestyle factors and mortality outcomes among colorectal cancer patients: a meta-analysis","volume":"117","author":"Chen","year":"2025","journal-title":"J. Natl. Cancer Inst. Internet"},{"key":"10.1016\/j.ctarc.2026.101486_bib0017","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1159\/000442831","article-title":"Dietary and lifestyle factors associated with colorectal cancer risk and interactions with microbiota: fiber, red or processed meat and alcoholic drinks","volume":"3","author":"Tuan","year":"2016","journal-title":"Gastrointest. Tumors. Internet"},{"key":"10.1016\/j.ctarc.2026.101486_bib0018","article-title":"Influence of the gut microbiome, diet, and environment on risk of colorectal cancer","author":"Song","year":"2020","journal-title":"Gastroenterol. Internet"},{"key":"10.1016\/j.ctarc.2026.101486_bib0019","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1080\/01635581.2023.2242103","article-title":"Food intake and colorectal cancer","volume":"75","author":"Kumar","year":"2023","journal-title":"Nutr. Cancer Internet"},{"key":"10.1016\/j.ctarc.2026.101486_bib0020","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1097\/JS9.0000000000002229","article-title":"Deciphering the impact of dietary habits and behavioral patterns on colorectal cancer","volume":"111","author":"Yuan","year":"2025","journal-title":"Int. J. Surg. Internet"},{"key":"10.1016\/j.ctarc.2026.101486_bib0021","article-title":"Colorectal cancer immunotherapy: options and strategies","volume":"11","author":"Johdi","year":"2020","journal-title":"Front Immunol. Internet"},{"key":"10.1016\/j.ctarc.2026.101486_bib0022","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/S0140-6736(19)32319-0","article-title":"Colorectal cancer","volume":"394","author":"Dekker","year":"2019","journal-title":"Lancet Internet"},{"issue":"7","key":"10.1016\/j.ctarc.2026.101486_bib0023","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1136\/gutjnl-2021-326264","article-title":"Cancer pharmacomicrobiomics: targeting microbiota to optimise cancer therapy outcomes","volume":"71","author":"Ting","year":"2022","journal-title":"Gut. Internet"},{"issue":"6","key":"10.1016\/j.ctarc.2026.101486_bib0024","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/nrgastro.2017.20","article-title":"Gut microbiota modulation of chemotherapy efficacy and toxicity","volume":"14","author":"Alexander","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol. Internet"},{"key":"10.1016\/j.ctarc.2026.101486_bib0025","article-title":"Role of diet in colorectal cancer incidence","volume":"4","author":"Veettil","year":"2021","journal-title":"Jama Netw. Open Internet"},{"issue":"October","key":"10.1016\/j.ctarc.2026.101486_bib0026","first-page":"1","article-title":"Probiotics as multifaceted oral vaccines against colon cancer: a review","volume":"13","author":"Singh","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ctarc.2026.101486_bib0027","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.trecan.2024.05.001","article-title":"Advancements in combining targeted therapy and immunotherapy for colorectal cancer","volume":"10","author":"Singh","year":"2024","journal-title":"Trends Cancer Internet"},{"key":"10.1016\/j.ctarc.2026.101486_bib0028","article-title":"The impact of pre-, pro- and synbiotics supplementation in colorectal cancer treatment: a systematic review","volume":"14","author":"Moreira","year":"2024","journal-title":"Front Oncol. Internet"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101486_bib0029","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1748-5908-5-69","article-title":"Scoping studies: advancing the methodology","volume":"5","author":"Levac","year":"2010","journal-title":"Implement. Sci."},{"issue":"7","key":"10.1016\/j.ctarc.2026.101486_bib0030","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation","volume":"169","author":"Tricco","year":"2018","journal-title":"Ann. Intern. Med. Internet"},{"issue":"2","key":"10.1016\/j.ctarc.2026.101486_bib0031","doi-asserted-by":"crossref","first-page":"356","DOI":"10.3390\/nu15020356","article-title":"Postoperative Probiotics administration attenuates gastrointestinal complications and gut microbiota dysbiosis caused by chemotherapy in colorectal cancer patients","volume":"15","author":"Huang","year":"2023","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101486_bib0032","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s12876-019-1047-4","article-title":"A randomized double-blind placebo-controlled trial of probiotics in post-surgical colorectal cancer","volume":"19","author":"Zaharuddin","year":"2019","journal-title":"BMC. Gastroenterol."},{"issue":"8","key":"10.1016\/j.ctarc.2026.101486_bib0033","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/sj.bjc.6603990","article-title":"Lactobacillus supplementation for diarrhoea related to chemotherapy of colorectal cancer: a randomised study","volume":"97","author":"\u00d6sterlund","year":"2007","journal-title":"Br. J. Cancer"},{"issue":"3","key":"10.1016\/j.ctarc.2026.101486_bib0034","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/ajco.12758","article-title":"Strain-specific probiotic (microbial cell preparation) and omega-3 fatty acid in modulating quality of life and inflammatory markers in colorectal cancer patients: a randomized controlled trial","volume":"14","author":"Golkhalkhali","year":"2018","journal-title":"Asia Pac. J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.ctarc.2026.101486_bib0035","first-page":"316","article-title":"Usage of probiotics and its clinical significance at surgically treated patients sufferig from colorectal carcinoma","volume":"73","author":"Bajramagic","year":"2019","journal-title":"Med. Arch."},{"issue":"3","key":"10.1016\/j.ctarc.2026.101486_bib0036","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.ctim.2015.03.008","article-title":"Prevention of irinotecan induced diarrhea by probiotics: a randomized double blind, placebo controlled pilot study","volume":"23","author":"Mego","year":"2015","journal-title":"Complement. Ther. Med."},{"key":"10.1016\/j.ctarc.2026.101486_bib0037","article-title":"414 A randomized phase II study of systemic therapy plus WeiLeShu (WLS) versus systemic therapy alone in patients with metastatic colorectal cancer (mCRC)","author":"Zhang","year":"2021","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.ctarc.2026.101486_bib0038","first-page":"225","article-title":"Effect of synbiotic supplementation on matrix metalloproteinase enzymes, quality of life and dietary intake and weight changes in rectal cancer patients undergoing neoadjuvant chemoradiotherapy","volume":"13","author":"Farshi Radvar","year":"2020","journal-title":"Med. J. Nutr Metab."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101486_bib0039","article-title":"Effect of probiotics combined with immune checkpoint suppressors and chemotherapeutic agents on digestive system function, intestinal immunity and prognosis in patients with metastatic colorectal carcinoma: a quasi-experimental study","volume":"25","author":"Wang","year":"2025","journal-title":"BMC. Gastroenterol."},{"issue":"2","key":"10.1016\/j.ctarc.2026.101486_bib0040","first-page":"110","article-title":"Role of probiotics and synbiotics in preventing chemoradiotherapy-associated toxicity in colorectal cancer patients: a systematic review","volume":"48","author":"Mahdavi","year":"2023","journal-title":"Iran J. Med. Sci. Internet"},{"issue":"27","key":"10.1016\/j.ctarc.2026.101486_bib0041","article-title":"Efficacy and safety of probiotics in preventing chemotherapy-related diarrhea in patients with colorectal cancer: a systematic review and meta-analysis based on 18 randomized trials","volume":"104","author":"Yang","year":"2025","journal-title":"Med. Internet"},{"key":"10.1016\/j.ctarc.2026.101486_bib0042","article-title":"Orally administered probiotics in the prevention of chemotherapy (\u00b1 Radiotherapy)-induced gastrointestinal toxicity: a systematic review with meta-analysis of randomized trials","volume":"21","author":"Danis","year":"2022","journal-title":"Integr Cancer Ther. Internet"},{"issue":"2","key":"10.1016\/j.ctarc.2026.101486_bib0043","doi-asserted-by":"crossref","first-page":"131","DOI":"10.15386\/mpr-2526","article-title":"Microbiome modulation in the prevention and management of colorectal cancer: a systematic review of clinical interventions","volume":"96","author":"Fratila","year":"2022","journal-title":"Med. Pharm. Rep. Internet"},{"issue":"2","key":"10.1016\/j.ctarc.2026.101486_bib0044","article-title":"Microbiome-modifiers for cancer-related fatigue management: a systematic review","volume":"40","author":"Belloni","year":"2024","journal-title":"Semin. Oncol. Nurs. Internet"},{"issue":"4","key":"10.1016\/j.ctarc.2026.101486_bib0045","first-page":"1160","article-title":"Role of probiotics in modulating Human gut microbiota populations and activities in patients with colorectal cancer\u2014a systematic review of clinical trials","volume":"13","author":"Wierzbicka","year":"2021","journal-title":"Nutr. Internet"},{"issue":"15","key":"10.1016\/j.ctarc.2026.101486_bib0046","doi-asserted-by":"crossref","first-page":"3563","DOI":"10.3390\/cancers14153563","article-title":"The effect of the gut microbiota on systemic and anti-tumor immunity and response to systemic therapy against cancer","volume":"14","author":"Aghamajidi","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.ctarc.2026.101486_bib0047","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1410928","article-title":"The role of the gut microbiota in tumor, immunity, and immunotherapy","volume":"15","author":"Xie","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ctarc.2026.101486_bib0048","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-024-01541-w","article-title":"Critical role of the gut microbiota in immune responses and cancer immunotherapy","volume":"17","author":"Li","year":"2024","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.ctarc.2026.101486_bib0049","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1038\/s41423-025-01326-2","article-title":"The gut microbiota in cancer immunity and immunotherapy","volume":"22","author":"Xie","year":"2025","journal-title":"Cell Mol. Immunol."},{"issue":"7","key":"10.1016\/j.ctarc.2026.101486_bib0050","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.trecan.2021.01.010","article-title":"Gut microbiota in cancer immune response and immunotherapy","volume":"7","author":"Zhou","year":"2021","journal-title":"Trends. Cancer"},{"key":"10.1016\/j.ctarc.2026.101486_bib0051","article-title":"Postbiotics in colorectal cancer: intervention mechanisms and perspectives","volume":"15","author":"Xie","year":"2024","journal-title":"Front Microbiol. Internet"},{"issue":"20","key":"10.1016\/j.ctarc.2026.101486_bib0052","article-title":"Microbial therapeutics in cancer: translating probiotics, prebiotics, synbiotics, and postbiotics from mechanistic insights to clinical applications: a topical review","volume":"39","author":"Tegegne","year":"2025","journal-title":"FASEB J. Internet"},{"issue":"19","key":"10.1016\/j.ctarc.2026.101486_bib0053","doi-asserted-by":"crossref","first-page":"4423","DOI":"10.1002\/cncr.33100","article-title":"MASCC\/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy","volume":"126","author":"Elad","year":"2020","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101486_bib0054","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/1751-2980.13247","article-title":"Efficacy and safety of probiotics, prebiotics, and synbiotics for the prevention of colorectal cancer and precancerous lesion in high-risk populations: a systematic review and meta-analysis of randomized controlled trials","volume":"25","author":"Kan","year":"2024","journal-title":"J. Dig Dis. Internet"},{"issue":"15","key":"10.1016\/j.ctarc.2026.101486_bib0055","first-page":"2501","article-title":"Gut-microbiota-derived metabolites and probiotic strategies in colorectal cancer: implications for disease modulation and precision therapy","volume":"17","author":"Yang","year":"2025","journal-title":"Nutr. Internet"},{"issue":"7","key":"10.1016\/j.ctarc.2026.101486_bib0056","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/s41430-024-01542-5","article-title":"Efficacy of probiotics or synbiotics supplementation on chemotherapy-induced complications and gut microbiota dysbiosis in gastrointestinal cancer: a systematic review and meta-analysis","volume":"79","author":"Yao","year":"2025","journal-title":"Eur. J. Clin. Nutr. Internet"},{"key":"10.1016\/j.ctarc.2026.101486_bib0057","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.clnesp.2025.10.031","article-title":"Decreased appetite in cancer patients treated with immune checkpoint inhibitors (ICIs): the MOUSEION-012 systematic review and meta-analysis","volume":"70","author":"Vitale","year":"2025","journal-title":"Clin. Nutr. ESPEN Internet"},{"issue":"2","key":"10.1016\/j.ctarc.2026.101486_bib0058","article-title":"Hyponatremia in cancer patients receiving immune checkpoint inhibitors: the ARON-MOUSEION-014 meta-analysis","volume":"45","author":"Vitale","year":"2026","journal-title":"Cancer Metastasis. Rev. Internet"},{"key":"10.1016\/j.ctarc.2026.101486_bib0059","doi-asserted-by":"crossref","first-page":"11107","DOI":"10.2147\/DDDT.S560518","article-title":"Infusion-related reactions among cancer patients receiving immune checkpoint inhibitors: the ARON-MOUSEION-013 systematic review and meta-analysis","volume":"Volume 19","author":"Vitale","year":"2025","journal-title":"Drug Devel. Ther. Internet"},{"key":"10.1016\/j.ctarc.2026.101486_bib0060","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-022-01273-9","article-title":"Gut microbiota influence immunotherapy responses: mechanisms and therapeutic strategies","volume":"15","author":"Lu","year":"2022","journal-title":"J. Hematol. Oncol."},{"issue":"16","key":"10.1016\/j.ctarc.2026.101486_bib0061","doi-asserted-by":"crossref","first-page":"7758","DOI":"10.3390\/ijms26167758","article-title":"Interconnection of gut microbiome and efficacy of immune checkpoint inhibitors in inoperable non-small-cell lung cancer","volume":"26","author":"Moiseenko","year":"2025","journal-title":"Int. J. Mol. Sci. Internet"},{"key":"10.1016\/j.ctarc.2026.101486_bib0062","first-page":"548","article-title":"Fusobacterium nucleatum promotes chemoresistance to colorectal cancer by modulating autophagy","volume":"170","author":"Yu","year":"2017","journal-title":"Cell Internet"},{"key":"10.1016\/j.ctarc.2026.101486_bib0063","article-title":"Gut microbiota as a hidden modulator of chemotherapy: implications for colorectal cancer treatment","volume":"16","author":"Sadeghloo","year":"2025","journal-title":"Discov. Oncol. Internet"},{"key":"10.1016\/j.ctarc.2026.101486_bib0064","article-title":"The impact of the microbiota on the immune response modulation in colorectal cancer","volume":"15","author":"Neagu","year":"2025","journal-title":"Biomol. Internet"},{"key":"10.1016\/j.ctarc.2026.101486_bib0065","article-title":"The role of gut microbiota in tumor recurrence and therapy resistance in colorectal cancer: molecular mechanisms and clinical implications","author":"Meneses","year":"2025","journal-title":"Jpn. J. Res. Internet"},{"key":"10.1016\/j.ctarc.2026.101486_bib0066","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1016\/j.chom.2025.08.013","article-title":"Bacteroides fragilis promotes chemoresistance in colorectal cancer, and its elimination by phage VA7 restores chemosensitivity","volume":"33","author":"Ding","year":"2025","journal-title":"Cell Host. Microbe. Internet"},{"key":"10.1016\/j.ctarc.2026.101486_bib0067","first-page":"1","article-title":"Gut microbiota in colorectal cancer development and therapy","author":"Wong","year":"2023","journal-title":"Nat. Rev. Clin. Oncol. Internet"},{"key":"10.1016\/j.ctarc.2026.101486_bib0068","article-title":"Exploring the impact of chemotherapy on the emergence of antibiotic resistance in the gut microbiota of colorectal cancer patients","volume":"14","author":"Kenneth","year":"2025","journal-title":"Antibiot. Internet"},{"key":"10.1016\/j.ctarc.2026.101486_bib0069","article-title":"Progress on the mechanism of intestinal microbiota against colorectal cancer","volume":"15","author":"Xing","year":"2025","journal-title":"Front Cell Infect. Microbiol. Internet"},{"key":"10.1016\/j.ctarc.2026.101486_bib0070","article-title":"The impact of the microbiome on resistance to cancer treatment with chemotherapeutic agents and immunotherapy","volume":"23","author":"\u0160ev\u010d\u00edkov\u00e1","year":"2022","journal-title":"Int. J. Mol. Sci. Internet"},{"key":"10.1016\/j.ctarc.2026.101486_bib0071","article-title":"The effects of tumor-derived supernatants (TDS) on cancer cell progression: a review and update on carcinogenesis and immunotherapy","volume":"40","author":"Ahmadpour","year":"2024","journal-title":"Cancer Treat Res. Commun. Internet"},{"key":"10.1016\/j.ctarc.2026.101486_bib0072","doi-asserted-by":"crossref","first-page":"4925","DOI":"10.1038\/s41388-020-1341-1","article-title":"Gut microbiota modulation: a novel strategy for prevention and treatment of colorectal cancer","volume":"39","author":"Fong","year":"2020","journal-title":"Oncogene Internet"},{"key":"10.1016\/j.ctarc.2026.101486_bib0073","article-title":"Fecal microbiota transplantation inhibits colorectal cancer progression: reversing intestinal microbial dysbiosis to enhance anti-cancer immune responses","volume":"14","author":"Yu","year":"2023","journal-title":"Front Microbiol. Internet"},{"key":"10.1016\/j.ctarc.2026.101486_bib0074","article-title":"Gut microbiota modulation: a tool for the management of colorectal cancer","volume":"20","author":"Wang","year":"2022","journal-title":"J. Transl. Med. Internet"},{"issue":"4","key":"10.1016\/j.ctarc.2026.101486_bib0075","doi-asserted-by":"crossref","first-page":"327","DOI":"10.2174\/0115733947259130231003044741","article-title":"Early detection of colorectal cancer: conventional techniques and current biomarkers","volume":"20","author":"Ahmadpour","year":"2024","journal-title":"Curr. Cancer Ther. Rev. Internet"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101486_bib0076","doi-asserted-by":"crossref","first-page":"10","DOI":"10.2174\/0115733947270529231116114913","article-title":"Alterations of the gut microbiome and metabolome following: a opportunity for early detection of colorectal cancer","volume":"21","author":"Modarres","year":"2025","journal-title":"Curr. Cancer Ther. Rev. Internet"},{"issue":"9","key":"10.1016\/j.ctarc.2026.101486_bib0077","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/cac2.12072","article-title":"Is post-transplant chemotherapy feasible in liver transplantation for colorectal cancer liver metastases?","volume":"40","author":"Brandi","year":"2020","journal-title":"Cancer Commun. Lond. Engl. Internet"},{"issue":"11","key":"10.1016\/j.ctarc.2026.101486_bib0078","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1038\/s41591-019-0626-9","article-title":"Genomic and epidemiological evidence of bacterial transmission from probiotic capsule to blood in ICU patients","volume":"25","author":"Yelin","year":"2019","journal-title":"Nat. Med. Internet"}],"container-title":["Cancer Treatment and Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294226003953?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294226003953?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T03:04:52Z","timestamp":1792033492000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468294226003953"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":78,"alternative-id":["S2468294226003953"],"URL":"https:\/\/doi.org\/10.1016\/j.ctarc.2026.101486","relation":{},"ISSN":["2468-2942"],"issn-type":[{"value":"2468-2942","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Microbiota modulation in colorectal cancer: A scoping review of its potential role in toxicity mitigation and treatment response","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment and Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctarc.2026.101486","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101486"}}